Photo from wikipedia
In the short term, continuous subcutaneous insulin infusion (CSII) has been associated with improved glycaemic control, reduced hypoglycaemia and improved quality of life (QOL). However, limited data are available on… Click to show full abstract
In the short term, continuous subcutaneous insulin infusion (CSII) has been associated with improved glycaemic control, reduced hypoglycaemia and improved quality of life (QOL). However, limited data are available on its long‐term benefits, particularly in the UK. We aimed to assess the impact of CSII on longer term outcomes.
Keywords:
subcutaneous insulin;
infusion csii;
insulin infusion;
csii;
continuous subcutaneous
Journal Title: Diabetic Medicine
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetic Medicine
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!